The Clinical Efficacy and Safety of <scp>ErhBMP</scp>‐2/<scp>BioCaP</scp>/β‐<scp>TCP</scp> as a Novel Bone Substitute Using the Tooth‐Extraction‐Socket‐Healing Model: A Proof‐of‐Concept Randomized Controlled Trial
This clinical trial primarily proved the safety and efficacy of ErhBMP-2/BioCaP/β-TCP as a promising bone substitute.
Authors
- Daniël Wismeijer
- Dedong Yu (ORCID: https://orcid.org/0000-0002-3142-475X)
- Lingfei Wei (ORCID: https://orcid.org/0000-0001-5035-4817)
- Herman Pieterse
- Yuelian Liu (ORCID: https://orcid.org/0000-0002-5472-6849)
- Yuanyuan Sun (ORCID: https://orcid.org/0000-0002-6515-134X)
- Yiqun Wu (ORCID: https://orcid.org/0000-0002-8352-6256)
Institutions
- Shandong University of Aeronautics (CN)
- Shanghai Jiao Tong University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Academic Center for Dentistry Amsterdam (NL)
- National Clinical Research Center for Digestive Diseases (CN)
- Shanghai Stomatological Hospital (CN)
- Shanghai Ninth People's Hospital (CN)
- Vrije Universiteit Amsterdam (NL)
- University of Amsterdam (NL)
Publication Details
- Journal
- Journal Of Clinical Periodontology
- Published
- 2024-10-31
- DOI
- https://doi.org/10.1111/jcpe.14084
- Citations
- 10
- Primary Topic
- Bone Tissue Engineering Materials
- Type
- article
- Field-Weighted Citation Impact
- 1.84
Funders
- National Natural Science Foundation of China
- ZonMw
- Natural Science Foundation of Shandong Province
- Shanghai Clinical Research Center